Cancer Trials
We offer a number of clinical trials for cancer. Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.
Page 1 of 4 | Results 1 - 10 of 36
Grace Makari-Judson, MD
Cancer - Breast,
Cancer
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
John McCann, MD
Cancer,
Cancer - Lung
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
The purpose of this study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without your cancer returning. The current standard treatment after chemotherapy is hormone treatment alone. The combination of hormone-treatment and everolimus is experimental in patients with breast cancer.
Grace Makari-Judson, MD
Cancer - Breast,
Cancer
D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
Grace Makari-Judson, MD
Cancer,
Cancer - Breast
D’Amour Center for Cancer Care
3350 Main Street
Springfield MA 01199
The purpose of this study is to test whether the use of a radiation therapy delivery technique called intensity-modulated radiation therapy (IMRT) can reduce the amount and severity of gastrointestinal side effects (such as diarrhea) that result from radiation, compared with standard radiation techniques
Seth Kaufman, MD
Cancer-Gynecologic,
Cancer
D’Amour Center for Cancer Care
3350 Main Street
Springfield MA 01199
The purpose of this study is to compare the effects of mFOLFIRINOX (oxaliplatin, irinotecan, and fluorouracil) and gemcitabine plus nab-paclitaxel. These chemotherapy drugs will be given before and after surgery. This study will allow the researchers to know if it is a good idea to treat pancreatic cancer with chemotherapy drugs before surgery and if so, to see which of the two drug combinations is better.
Chandravathi Loke, MD
Cancer - Pancreatic,
Cancer
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
The purpose of this research study is to compare any good and bad effects of giving ipilimumab, nivolumab, and GM-CSF (Sargramostim) at the same time compared to just ipilimumab and nivolumab together. We would also like to find out what effects, good and bad, that this combination of drugs may have on your cancer.
John McCann, MD
Cancer - Melanoma,
Cancer
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
Tashanna Myers, MD
Cancer-Gynecologic,
Cancer
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Syed Ali, MD
Cancer - Lymphoma,
Cancer
D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA
Baystate Franklin Medical Center
164 High Street
Greenfield, MA
Leslie Howard, MD
Cancer,
Cancer - Kidney
D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199
Page 1 of 4 | Results 1 - 10 of 36